Recombinant Mouse Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB (Man1a2)

What is the primary molecular function of Man1a2 in glycoprotein processing?

Man1a2 (Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB) functions primarily as an enzyme that cleaves excess mannose residues during the maturation process of N-glycans . This trimming is essential for proper glycoprotein processing and maturation within the Golgi apparatus. The enzyme specifically targets alpha-linked mannose residues in oligosaccharides originating from N-linked glycans . The molecular function of Man1a2 extends beyond simple glycan processing, as it participates in regulating the proper folding of proteins through its involvement in the quality control mechanisms associated with the endoplasmic reticulum (ER) and Golgi apparatus . Deficiency in Man1a2 leads to accumulation of improperly processed glycoproteins, which can trigger ER stress and unfolded protein response (UPR) pathways, ultimately affecting multiple developmental processes and cellular functions .

How does Man1a2 deficiency affect N-glycosylation patterns in affected tissues?

In models with Man1a2 deficiency, there is significant evidence of hypermannosylation of glycoproteins . Analysis of oligosaccharides derived from cathepsin B in alpha-mannosidosis mice demonstrates the presence of elongated N-linked oligosaccharides, specifically extended Man3GlcNAc2 structures . Two-dimensional difference gel electrophoresis, deglycosylation assays, and mass spectrometry have confirmed that native lysosomal proteins exhibit abnormally elongated N-linked oligosaccharides in these models .

The dysregulation of N-glycan processing caused by Man1a2 deficiency has cascading effects on protein folding and function. This enzyme deficiency leads to accumulation of unfolded or misfolded proteins, resulting in Golgi-ER stress and activation of the Xbp1-ATF mediated unfolded protein response . These abnormal glycosylation patterns directly impact multiple developmental processes, including those regulated by developmental signaling pathways such as sonic hedgehog (Shh), Notch, and Wnt signaling .

What molecular pathways interact with Man1a2 in development and disease?

Man1a2 participates in extensive molecular crosstalk with several critical developmental pathways. Transcriptomic analyses of Man1a2 mutant tissues have revealed interactions with:

• CPLANE network proteins: Man1a2 deficiency affects the CPLANE (Ciliogenesis and Planar Polarity Effector) network, which is crucial for cilia formation and function .

• Developmental signaling pathways: Man1a2 interacts with hedgehog signaling (via Shh), Notch signaling (through Notch1 and Notch4), and Wnt signaling (via Ctnnb1) .

• Stress response pathways: Man1a2 deficiency triggers multiple stress responses, including:

  • Unfolded protein response (UPR)

  • Hypoxia signaling

  • Oxidative stress response

• EGFR signaling: In zebrafish models, man1a2 knockdown dysregulates egfra and other developmental genes .

Protein-protein interaction network analysis demonstrates that abnormal N-glycan synthesis affecting Man1a2 function influences developmental pathways through cross-talk between these functional modules, recruiting stress responses that can be mitigated with interventions like N-acetylcysteine (NAC) .

What knockout models are available for studying Man1a2 function, and what are their key phenotypes?

Several experimental models have been developed to study Man1a2 function:

Mouse knockout models:

• Man1a2 -/- (homozygous): These mice develop lethal respiratory failure shortly after birth due to homozygous deletion of the second Man1a2 exon . They exhibit:

  • Unexpanded alveoli and thick interalveolar lung septa

  • Decreased lung ciliation measured by Arl13b+ respiratory epithelial cells

  • Portal expansion, inflammation, and ductular reaction in the liver

  • Complete loss of exon 2 expression and reduced expression of mid-level and terminal exons

• Man1a2 +/- (heterozygous): These mice show intermediate defects, including:

  • Reduced survival compared to wild-type but better than null homozygotes

  • Intermediate defects in lung ciliation

  • Partial rescue possible with N-acetylcysteine (NAC) treatment during gestation

Zebrafish knockdown models:

• man1a2 morpholino knockdown: Zebrafish embryos with man1a2 knockdown demonstrate:

  • Poor biliary network formation

  • Ciliary dysgenesis in Kupffer's vesicle

  • Cardiac and liver heterotaxy

  • Dysregulated egfra and other developmental genes

These models provide complementary systems for studying the role of Man1a2 in different developmental contexts and organ systems.

How can Man1a2 activity be assessed in experimental settings?

Assessment of Man1a2 activity involves multiple approaches:

• Gene expression analysis:

  • RT-qPCR to measure expression of Man1a2 exons (particularly exon 2, which is deleted in knockout models)

  • Analysis of mid-level (exon 5-6 junction) and terminal (exon 11-12 junction) exons to assess expression levels

• Protein glycosylation assessment:

  • Two-dimensional difference gel electrophoresis to visualize altered glycoprotein migration patterns

  • Deglycosylation assays to compare glycosylation states between wild-type and Man1a2-deficient samples

  • Mass spectrometry to characterize oligosaccharide structures (particularly useful for identifying hypermannosylated products)

• Phenotypic evaluation:

  • Immunostaining for ciliary markers (e.g., Arl13b) to assess ciliation in respiratory epithelial cells

  • Histological evaluation of affected tissues (lung, liver) to detect developmental abnormalities

  • Assessment of survival rates in animal models with varying Man1a2 genotypes

• Functional rescue experiments:

  • Treatment with recombinant human alpha-mannosidase to assess correction of hyperglycosylation

  • N-acetylcysteine (NAC) administration to evaluate rescue of phenotypes through amelioration of oxidative stress

What approaches are effective for investigating Man1a2's role in ciliogenesis?

Man1a2's role in ciliogenesis can be effectively investigated using the following approaches:

• Ciliary visualization techniques:

  • Immunostaining for Arl13b, a regulatory GTPase highly enriched in cilia, allows quantification of ciliated cells in respiratory epithelium

  • Confocal microscopy to assess ciliary morphology and distribution in affected tissues

• Ciliary functional assays:

  • In cultured mouse airway epithelium, Man1a2 knockdown arrests ciliary development and motility, providing a model to study ciliary dynamics

  • Analysis of ciliary beat frequency and pattern in airway epithelial cultures

• Developmental laterality assessment:

  • Evaluation of left-right patterning defects in zebrafish embryos with man1a2 knockdown

  • Assessment of heart and liver positioning to detect heterotaxy, which stems from ciliary dysfunction in embryonic nodal structures

• Transcriptomic profiling:

  • Analysis of ciliary gene expression patterns in Man1a2-deficient tissues

  • Investigation of dysregulated ciliary pathways, particularly those involved in CPLANE networks

• Synergistic knockdown experiments:

  • Combined knockdown of Man1a2 with EGFR signaling components or other ciliary genes to assess pathway interactions

  • Sub-optimal knockdowns that individually produce minimal effects can reveal synergistic roles when combined

How does Man1a2 deficiency affect lung development and respiratory function?

Man1a2 deficiency impacts lung development and respiratory function through multiple mechanisms:

• Structural abnormalities:

  • Man1a2 -/- mice develop unexpanded alveoli and thick interalveolar lung septa

  • These structural defects contribute to respiratory failure in newborn pups with homozygous deletion of Man1a2 exon 2

• Impaired ciliation:

  • Homozygous Man1a2 -/- mutants show dramatically reduced lung ciliation as measured by the frequency of Arl13b+ respiratory epithelial cells

  • Heterozygous Man1a2 +/- pups develop intermediate defects in lung ciliation

  • Ciliation defects decrease in a genotype-dependent manner, with wild-type > heterozygous > homozygous null

• Developmental pathway dysregulation:

  • Man1a2 deficiency affects multiple developmental pathways critical for lung development, including hedgehog signaling, Notch signaling, and Wnt signaling

  • Blood vessel development and tube morphogenesis processes are significantly impacted

• Oxidative stress and UPR activation:

  • Man1a2 mutation impairs oxidative stress response pathways essential for proper lung development

  • The resulting UPR can lead to oxidative stress and hypoxic response, further impairing lung development

• Treatment responsiveness:

  • Gestational treatment with N-acetylcysteine (NAC) improves lung ciliation in heterozygous pups and increases their survival

  • NAC treatment also increases lung ciliation in null pups but is insufficient to prevent lethality

What is the relationship between Man1a2 and biliary atresia pathogenesis?

Man1a2 has emerged as a significant contributor to biliary atresia (BA) pathogenesis:

• Genetic association:

  • Single nucleotide polymorphisms (SNPs) in Man1a2 have been significantly associated with BA requiring liver transplantation

  • Top-ranked SNPs include rs6657965 (flanking), rs12131109 and rs7531715 (intronic) with significantly higher minor allele frequencies in BA cases

• Biliary morphogenesis:

  • In zebrafish embryos, man1a2 knockdown causes poor biliary network formation

  • Man1a2 -/- mice exhibit portal expansion, inflammation, and ductular reaction in the liver, suggestive of biliary inflammation

• Ciliary dysgenesis:

  • Man1a2 regulates ciliogenesis, which is critical for proper hepatobiliary morphogenesis

  • Man1a2 knockdown causes ciliary dysgenesis in Kupffer's vesicle in zebrafish embryos

• Developmental pathway interactions:

  • Man1a2 knockdown dysregulates EGFR signaling pathway genes

  • Suboptimal man1a2 knockdown synergizes with suboptimal EGFR signaling or adenosine-ribosylation-factor-6 knockdown to reproduce biliary defects

• Laterality defects:

  • Man1a2 deficiency can lead to cardiac and liver heterotaxy due to ciliary dysfunction

  • The gene regulates laterality in addition to hepatobiliary morphogenesis through its effects on ciliogenesis

A key finding is that BA liver samples and Man1a2 -/- liver exhibit reduced Man1a2 expression and dysregulated ciliary genes known to cause multisystem human laterality defects, providing a developmental basis for the multisystem defects observed in BA .

How does Man1a2 function integrate with ciliary development across different organ systems?

Man1a2 plays a central role in ciliary development across multiple organ systems through several integrated mechanisms:

• Cross-tissue effects on ciliogenesis:

  • In respiratory epithelium, Man1a2 is essential for proper ciliation, with knockdown or knockout leading to reduced Arl13b+ ciliated cells

  • In cultured mouse airway epithelium, Man1a2 knockdown arrests ciliary development and motility

  • In zebrafish embryos, man1a2 knockdown causes ciliary dysgenesis in Kupffer's vesicle, affecting left-right patterning

• Regulation of ciliary gene networks:

  • Man1a2 deficiency dysregulates numerous ciliary genes and pathways

  • Transcriptome analysis of Man1a2 null tissues reveals affected pathways include hedgehog, epidermal growth factor, and transforming growth factor signaling

  • These pathways have significant roles in branching morphogenesis of epithelial duct networks during organ development

• CPLANE network interactions:

  • Man1a2 interacts with the CPLANE (Ciliogenesis and Planar Polarity Effector) network

  • Abnormal glycosylation affecting Man1a2 function influences CPLANE network proteins critical for ciliary development

  • Protein-protein interaction network analysis reveals extensive crosstalk between N-glycan synthesis, CPLANE network, and developmental pathways

• Organ-specific manifestations:

  • Lung: Decreased ciliation of respiratory epithelial cells

  • Liver/Biliary system: Poor biliary network formation and portal inflammation

  • Cardiovascular system: Cardiac heterotaxy due to defective left-right patterning

• Common developmental origin:

  • The effects of Man1a2 on different organ systems suggest common developmental mechanisms underlying seeming disparate phenotypes

  • This supports the hypothesis that isolated and syndromic forms of conditions like biliary atresia may share common origins through ciliary dysfunction

What approaches are most effective for studying the interaction between Man1a2 and oxidative stress pathways?

Investigating the interaction between Man1a2 and oxidative stress pathways requires sophisticated approaches:

These approaches collectively provide a framework for understanding how Man1a2 deficiency leads to oxidative stress and how this stress contributes to the observed developmental phenotypes.

How do genetic variants in Man1a2 contribute to disease susceptibility in biliary atresia?

Genetic variants in Man1a2 contribute to biliary atresia (BA) susceptibility through several mechanisms:

• Association strength and replication:

  • Genome-wide association testing identified multiple SNPs in Man1a2 significantly associated with BA

  • Top-ranked flanking SNP rs6657965 showed significantly higher minor allele frequency in both discovery (p = 7.18E-05) and replication cohorts (p = 9.73E-04)

  • Intronic SNPs rs12131109 and rs7531715 in linkage disequilibrium (r2 > 0.8) also showed significantly higher frequencies in BA cases

• Expression regulation effects:

  • Man1a2 SNPs associated with BA are also linked with polymorphisms known to affect Man1a2 expression

  • These variants were not differentially enriched in either isolated or syndromic BA subtypes, suggesting common mechanisms

• Synergistic effects with other pathways:

  • Suboptimal man1a2 knockdown can synergize with suboptimal EGFR signaling or adenosine-ribosylation-factor-6 knockdown

  • This synergy reproduces biliary defects even when individual knockdowns have minimal effects, suggesting a multi-hit model of disease susceptibility

• Developmental basis for phenotypic spectrum:

  • Man1a2 variants affect ciliogenesis, providing a developmental basis for the multisystem defects observed in BA

  • This explains why "isolated" BA is still associated with minor extrahepatic gut and cardiovascular anomalies

• Variable penetrance explanation:

  • The synergistic interaction between Man1a2 and other pathways helps explain variable penetrance of disease

  • Different combinations of suboptimal pathway functioning can result in similar phenotypes with varying severity

These findings support a model where genetic variants in Man1a2 contribute to BA susceptibility through effects on ciliogenesis and laterality determination, regardless of BA subtype, providing a novel developmental basis for multisystem defects in this condition.

What is the current understanding of Man1a2's role in protein quality control and the unfolded protein response?

Man1a2 plays a crucial role in protein quality control and the unfolded protein response (UPR) through its function in N-glycan processing:

• N-glycan processing and protein folding:

  • Man1a2 cleaves excess mannose residues during the maturation of N-glycans, a critical step in glycoprotein processing

  • This process is regulated in part by UPR proteins, including X-box linked protein-1 (Xbp1) acting alone or with activating transcription factors 6 and 4 (ATF6 and ATF4)

• Consequences of Man1a2 deficiency:

  • Man1a2 deficiency leads to accumulation of improperly processed glycoproteins with hypermannosylated structures

  • The mutant enzyme promotes accumulation of unfolded or misfolded proteins resulting in Golgi-ER stress

  • This stress activates the Xbp1-ATF mediated UPR

• Cascade of cellular responses:

  • UPR activation triggers oxidative stress and hypoxic response

  • These responses are further potentiated by altered CPLANE and lung developmental proteins

  • Abnormal microtubular architecture affects organellar morphology, compounding the issue

• Developmental pathway effects:

  • The UPR triggered by Man1a2 deficiency directly influences developmental mechanisms mediated by:

    • Sonic hedgehog (Shh) signaling

    • Notch signaling (e.g., Notch1 and Notch4)

    • Wnt signaling (e.g., Ctnnb1)

• Therapeutic implications:

  • N-acetylcysteine (NAC) can reverse UPR-related changes by:

    • Replenishing glutathione to counter oxidative stress

    • Upregulating Hsp70 leading to a more efficient UPR

  • Treatment with recombinant human alpha-mannosidase partially corrects the hyperglycosylation of lysosomal proteins in vivo and in vitro

This understanding provides a mechanistic link between Man1a2's enzymatic function in glycan processing and its broader role in development through regulation of protein folding quality control and stress responses.

What rescue strategies have proven effective for Man1a2 deficiency phenotypes?

Several rescue strategies have shown effectiveness in ameliorating Man1a2 deficiency phenotypes:

• N-acetylcysteine (NAC) treatment:

  • Gestational treatment of heterozygous parents with NAC improved lung ciliation and survival of heterozygous pups

  • NAC treatment increased lung ciliation in null pups but was insufficient to prevent lethality

  • NAC likely works through multiple mechanisms:

    • Replenishing glutathione to counter oxidative stress

    • Upregulating Hsp70 leading to more efficient UPR

    • Upregulating Nfkb1 which promotes alveolarization

• Recombinant enzyme therapy:

  • Treatment with recombinant human alpha-mannosidase partially corrected the hyperglycosylation of lysosomal proteins in vivo and in vitro

  • This approach directly addresses the enzymatic deficiency by providing functional enzyme to process accumulated substrates

• Targeting vascular development:

  • Comparative analysis suggests blood vessel development and tube morphogenesis as critical processes affected by Man1a2 deficiency

  • NAC promotes vasodilation of vessels via effects on endothelial cells and inhibits monocyte adhesion to endothelial cells

  • These vascular effects may contribute to the rescue of developmental phenotypes

• Degree of rescue considerations:

  • The degree of phenotypic rescue appears to depend on the severity of Man1a2 deficiency

  • Heterozygous phenotypes show better response to rescue strategies than homozygous null phenotypes

  • This suggests a threshold effect where severe enzymatic deficiency may be less amenable to rescue

These findings provide a foundation for developing more targeted therapeutic approaches for conditions associated with Man1a2 deficiency, particularly those affecting lung development and biliary function.

What considerations are important when designing experiments to investigate Man1a2's role in developmental pathways?

Designing experiments to investigate Man1a2's role in developmental pathways requires careful consideration of several factors:

• Genetic dosage effects:

  • Man1a2 deficiency exhibits gene dosage-dependent effects on phenotypes

  • Experiments should include both heterozygous and homozygous models to capture the spectrum of effects

  • Survival and ciliation decrease in a genotype-dependent manner, suggesting the importance of quantitative assessment

• Developmental timing:

  • Man1a2's effects on development are likely stage-specific

  • Temporal control of gene knockdown/knockout or rescue interventions is crucial

  • Gestational timing of interventions like NAC treatment significantly impacts outcomes

• Tissue-specific effects:

  • Man1a2 deficiency manifests differently across tissues (lung, liver, etc.)

  • Experimental designs should incorporate multiple tissue assessments

  • System-specific markers (e.g., Arl13b for cilia) should be selected appropriately

• Pathway interactions and synergy:

  • Suboptimal knockdown of Man1a2 can synergize with suboptimal disruption of other pathways

  • Experimental designs should consider combinatorial manipulations to reveal synergistic effects

  • This approach can uncover interactions that might be missed in single-gene studies

• Multiple assessment methodologies:

  • Integrating multiple assessment approaches provides more comprehensive insights:

    • Molecular (transcriptomics, proteomics)

    • Cellular (immunostaining, electron microscopy)

    • Functional (survival, organ function)

    • Structural (histology, imaging)

• Translational relevance:

  • Comparative analyses between animal models and human samples enhance translational significance

  • Including human tissue samples or datasets when available provides validation

  • Consideration of clinically relevant endpoints strengthens experimental design

By incorporating these considerations, researchers can design more robust experiments to elucidate Man1a2's complex roles in developmental pathways across organ systems.

How can transcriptomic and systems biology approaches enhance our understanding of Man1a2 function?

Transcriptomic and systems biology approaches provide powerful tools for understanding Man1a2 function in development and disease:

• Comprehensive pathway mapping:

  • Protein-protein interaction (PPI) network analysis reveals extensive regulatory crosstalk between key genes

  • Integration of differentially expressed genes from Man1a2-deficient tissues into functional networks demonstrates interconnections between:

    • N-Glycan Synthesis

    • Unfolded Protein Response (UPR)

    • Oxidative Stress

    • Glutathione Metabolism

    • Hypoxia Response

    • Lung Development

    • CPLANE network

• Comparative transcriptomics:

  • Comparative enrichment analysis between mouse models and human developmental transcriptomes reveals conserved mechanisms

  • Analysis of 3,223 genes from developing human fetal lung compared with 847 genes from mouse models identified common enriched cellular components:

    • Golgi or endoplasmic reticulum

    • Microtubular cytoskeleton

    • Plasma membrane

• Treatment response profiling:

  • Transcriptomic analysis before and after interventions (e.g., NAC treatment) reveals mechanisms of rescue

  • Identification of key molecular functions like oxidative stress that are uniquely enriched in treated tissues

• Mechanistic network construction:

  • Building mechanistic networks representing regulatory crosstalk between key genes

  • Color-coding nodes to represent different functional mechanisms involved in processes like lung development:

    • Man1a2 N-Glycan Synthesis

    • Unfolded Protein Response

    • Oxidative Stress

    • Glutathione Metabolism

    • Hypoxia Response

    • Lung Development

    • CPLANE network

• Integration of multi-omics data:

  • Combining transcriptomic data with:

    • Proteomic analyses to assess post-translational modifications

    • Glycomic profiling to directly analyze N-glycan structures

    • Phenotypic data to correlate molecular changes with functional outcomes

These approaches collectively provide a systems-level understanding of how Man1a2 deficiency affects multiple interconnected pathways, offering insights into the complex developmental phenotypes observed and potential points for therapeutic intervention.